Neutralizing the Impact of the Virulence Factor LecA from Pseudomonas aeruginosa on Human Cells with New Glycomimetic Inhibitors.


Journal

Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Titre abrégé: Angew Chem Int Ed Engl
Pays: Germany
ID NLM: 0370543

Informations de publication

Date de publication:
06 02 2023
Historique:
received: 21 10 2022
pubmed: 19 11 2022
medline: 7 2 2023
entrez: 18 11 2022
Statut: ppublish

Résumé

Bacterial adhesion, biofilm formation and host cell invasion of the ESKAPE pathogen Pseudomonas aeruginosa require the tetravalent lectins LecA and LecB, which are therefore drug targets to fight these infections. Recently, we have reported highly potent divalent galactosides as specific LecA inhibitors. However, they suffered from very low solubility and an intrinsic chemical instability due to two acylhydrazone motifs, which precluded further biological evaluation. Here, we isosterically substituted the acylhydrazones and systematically varied linker identity and length between the two galactosides necessary for LecA binding. The optimized divalent LecA ligands showed improved stability and were up to 1000-fold more soluble. Importantly, these properties now enabled their biological characterization. The lead compound L2 potently inhibited LecA binding to lung epithelial cells, restored wound closure in a scratch assay and reduced the invasiveness of P. aeruginosa into host cells.

Identifiants

pubmed: 36398566
doi: 10.1002/anie.202215535
pmc: PMC10107299
doi:

Substances chimiques

Adhesins, Bacterial 0
Virulence Factors 0
Galactosides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202215535

Informations de copyright

© 2022 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.

Références

Org Biomol Chem. 2015 Nov 28;13(44):10923-8
pubmed: 26372329
Angew Chem Int Ed Engl. 2021 Apr 6;60(15):8104-8114
pubmed: 33314528
Chem Commun (Camb). 2012 Apr 25;48(33):4008-10
pubmed: 22428159
Microbiology (Reading). 2005 May;151(Pt 5):1313-1323
pubmed: 15870442
FEBS Lett. 2006 Feb 6;580(3):982-7
pubmed: 16438968
Rom J Morphol Embryol. 2014;55(4):1401-8
pubmed: 25611273
J Med Chem. 2016 Jul 14;59(13):5929-69
pubmed: 26804741
Nat Rev Drug Discov. 2003 Feb;2(2):114-22
pubmed: 12563302
FEBS Lett. 2003 Dec 4;555(2):297-301
pubmed: 14644431
Angew Chem Int Ed Engl. 2017 Dec 22;56(52):16559-16564
pubmed: 28960731
Org Biomol Chem. 2016 Aug 16;14(33):7933-48
pubmed: 27488655
Biochim Biophys Acta Mol Cell Res. 2017 Jul;1864(7):1236-1245
pubmed: 28428058
Curr Opin Chem Biol. 2019 Dec;53:51-67
pubmed: 31470348
J Org Chem. 2019 Mar 1;84(5):2470-2488
pubmed: 30681333
ACS Chem Biol. 2013 Sep 20;8(9):1925-30
pubmed: 23869965
mBio. 2020 Mar 10;11(2):
pubmed: 32156827
Cell Mol Life Sci. 2021 Apr;78(7):3637-3656
pubmed: 33555391
Int J Med Sci. 2008;5(6):371-6
pubmed: 19043609
Angew Chem Int Ed Engl. 2011 Nov 4;50(45):10631-5
pubmed: 21919164
J Med Chem. 2019 Oct 24;62(20):9201-9216
pubmed: 31553873
Org Biomol Chem. 2013 Sep 25;11(40):6906-18
pubmed: 24057051
Chem Sci. 2016 Aug 1;7(8):4990-5001
pubmed: 30155149
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12895-900
pubmed: 25136128
Nanoscale. 2021 Feb 25;13(7):4016-4028
pubmed: 33503085
Chem Asian J. 2018 Mar 16;13(6):686-700
pubmed: 29380519
Angew Chem Int Ed Engl. 2014 Aug 18;53(34):8885-9
pubmed: 25044671
J Am Chem Soc. 2018 Feb 21;140(7):2537-2545
pubmed: 29272578
Chem Commun (Camb). 2020 Aug 4;56(62):8822-8825
pubmed: 32628229
ACS Chem Biol. 2013 Aug 16;8(8):1775-84
pubmed: 23719508
Nat Rev Drug Discov. 2009 Aug;8(8):661-77
pubmed: 19629075
J Chem Theory Comput. 2021 Apr 13;17(4):2488-2501
pubmed: 33794087
Environ Microbiol. 2006 Jun;8(6):1095-104
pubmed: 16689730
Chem Rev. 2015 Jan 14;115(1):525-61
pubmed: 25495138
Angew Chem Int Ed Engl. 2023 Feb 6;62(7):e202215535
pubmed: 36398566
Clin Infect Dis. 2003 Aug 15;37(4):543-50
pubmed: 12905139
J Infect Dis. 2008 Apr 15;197(8):1079-81
pubmed: 18419525
Front Microbiol. 2016 May 31;7:811
pubmed: 27303392

Auteurs

Eva Zahorska (E)

Chemical Biology of Carbohydrates (CBCH), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, 66123, Saarbrücken, Germany.
Department of Chemistry, Saarland University, 66123, Saarbrücken, Germany.
Deutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-, Braunschweig, Germany.

Francesca Rosato (F)

Faculty of Biology, University of Freiburg, 79104, Freiburg, Germany.
Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104, Freiburg, Germany.

Kai Stober (K)

Faculty of Biology, University of Freiburg, 79104, Freiburg, Germany.
Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104, Freiburg, Germany.

Sakonwan Kuhaudomlarp (S)

Université Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, France.
Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.
Center for Excellence in Protein and Enzyme Technology, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.

Joscha Meiers (J)

Chemical Biology of Carbohydrates (CBCH), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, 66123, Saarbrücken, Germany.
Department of Chemistry, Saarland University, 66123, Saarbrücken, Germany.
Deutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-, Braunschweig, Germany.

Dirk Hauck (D)

Chemical Biology of Carbohydrates (CBCH), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, 66123, Saarbrücken, Germany.
Department of Chemistry, Saarland University, 66123, Saarbrücken, Germany.
Deutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-, Braunschweig, Germany.

Dorina Reith (D)

Faculty of Biology, University of Freiburg, 79104, Freiburg, Germany.
Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104, Freiburg, Germany.

Emilie Gillon (E)

Université Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, France.

Katharina Rox (K)

Deutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-, Braunschweig, Germany.
Department of Chemical Biology (CBIO), Helmholtz Centre for Infection Research (HZI), 38124, Braunschweig, Germany.

Anne Imberty (A)

Université Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, France.

Winfried Römer (W)

Faculty of Biology, University of Freiburg, 79104, Freiburg, Germany.
Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104, Freiburg, Germany.
Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, 79104, Freiburg, Germany.

Alexander Titz (A)

Chemical Biology of Carbohydrates (CBCH), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, 66123, Saarbrücken, Germany.
Department of Chemistry, Saarland University, 66123, Saarbrücken, Germany.
Deutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-, Braunschweig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH